Register here for FREE training to treat Opioid Use Disorder (OUD)
and qualify for the waiver to prescribe buprenorphine.
This free training for providers will be conducted by the American Society of Addiction Medicine (ASAM)* and includes:
Four hours of online training at your own pace
Four hours of live, interactive training from 9:30 a.m. - 2:00 p.m. (ET)
You can participate in one of three ways:
- In person: Travel to Centene in St. Louis, MO
- Join us at our NH Healthy Families Bedford office for live streaming of the training event (includes complimentary lunch). You must RSVP one week prior to training at NH_Healthy_Families_RSVP@centene.com
- Please use the following in your email subject: Provider Training
- Please include your training date
- Attend remotely by streaming on your device
And you’ll also get for FREE:
Continuing Medical Education Available
A copy of the ASAM National Practice Guideline
A reference guide and other clinical resources
The live sessions will be held in St. Louis, MO from 9:30 a.m. to 2:00 p.m. EST on four dates. Choose the one that fits your schedule:
The three dates in pink (+) feature curriculum designed for women’s health providers in partnership with the American College of Obstetricians and Gynecologists (ACOG).
Can’t make it there on those dates? You can also participate in the live training session of your choice by streaming it on your device.
*ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training.
**Substance Abuse and Mental Health Services Administration. (2017). Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/.
Overview of Legislation:
The Drug Abuse Treatment Act of 2000 (DATA 2000) specifies training is necessary for physicians to obtain a waiver to engage in office-based treatment of opioid use disorders using drugs approved by the FDA on Schedules III, IV, and V. This course addresses those requirements using a curriculum approved by CSAT/SAMHSA and ASAM, who is one of the national organizations named in the DATA 2000 legislation as eligible to prepare and administer these courses.